Procreation

Infertility global challenge, in Italy 8,000 cancer patients and 15% of couples affected

The University of Pavia has set up a master's course with the aim of providing solid skills in the field of clinical and experimental embryology

3' min read

Translated by AI
Versione italiana

3' min read

Translated by AI
Versione italiana

The World Health Organisation has defined infertility as a pathology that afflicts 15% of couples of reproductive age (60 thousand new cases per year in Italy). In addition to this, there are cancer patients of childbearing age (8 thousand per year in Italy), both men and women, undergoing gonadotoxic treatments that can cause infertility.

A university master's degree in infertility in Pavia

The University of Pavia has envisaged a Master's degree programme with the aim of providing solid skills in the field of clinical and experimental embryology and applied bioinformatics and bioengineering sciences.

Loading...

The initiative is part of a rapidly changing demographic context. In Italy, women become mothers for the first time on average at the age of 33.8 and the average number of children per woman is 1.18. A picture that not only represents a socio-medical emergency, but also has significant economic implications. The relevance of the issue is also confirmed at international level. The World Health Organisation considers infertility to be a global challenge and emphasises the need for integrated responses, from timely information to the prevention of risk factors, to access to diagnostic services and psychological support.

Medically assisted reproduction on the rise

A current market analysis notes that according to the European Society of Human Reproduction and Embryology and the Istituto Superiore di Sanità's Medical Assisted Reproduction (PMA) registry, more than 1,300 PMA clinics are active in Europe, 300 of which are in Italy alone.

In the USA, one out of every 60 babies is born thanks to PMA techniques.

In Denmark, Israel and Japan one in 25. Worldwide, there are more than 70 pharmaceutical and technology companies working directly in the field of reproductive medicine.

The Master of the University of Pavia is aimed at graduates from the scientific disciplines specified in the admission requirements.

Career opportunities will be mainly in the field of human and veterinary reproductive biology in clinical, management, experimental and production settings.

An annual term with symposia and internships

The Master includes five evening symposia in the Aula Goldoniana of the Ghislieri College. Denatality, on fertility preservation, sexual health and quality of life, philosophical perspectives and communication. ".

The symposium series is promoted by the 'L. Spallanzani' Department of Biology and Biotechnology at the University of Pavia, in collaboration with the Genera Group, an Italian group specialising in the diagnosis and treatment of infertility.

The strength of this master's degree, which defines its originality and attractiveness, is represented by 500 hours of internships to be carried out within Italian and European partner companies, such as PMA clinics (including those belonging to the Genera group), genetic analysis laboratories chemical and pharmaceutical industries and production of specific instruments for the clinical embryology laboratory, and the acquisition of the most advanced technologies in the bioinformatics and bioengineering fields that, through the use of artificial intelligence, nano-technologies and genetic engineering, will revolutionise both the diagnosis and treatment of infertility.

The Pavia Master's degree is one of the few Master's courses in Italy in the field of reproductive biology and embryology, which includes a strong experimental, technological and industrial as well as clinical focus along the course.

Teaching modules in Italian and English

The teaching modules will be taught in a mixed mode, both face-to-face and remotely. The Master's language is Italian, but some lectures, given by experts from both academia and foreign industries, will be conducted in English. In addition, some of these lectures will be held in the form of live streaming online seminars. The Master's course lasts one year and has a total of 1500 hours. At the end of the Master's course, participants who have carried out all the activities and fulfilled all the requirements, after passing the final examination, will be awarded the second-level university Master's degree in 'Biology and Biotechnology of Reproduction: from research to the clinic'.

Copyright reserved ©
Loading...

Brand connect

Loading...

Newsletter

Notizie e approfondimenti sugli avvenimenti politici, economici e finanziari.

Iscriviti